Cargando…

Regulatory Safety Learning Driven by the Mechanism of Action: The Case of TNF‐α Inhibitors

The summary of product characteristics (SmPCs) is an important information source that includes the adverse drug reactions (ADRs) associated with the drug. Drugs with the same mechanism of action are expected to have a similar ADR profile and thus a substantial overlap of the described ADRs in the S...

Descripción completa

Detalles Bibliográficos
Autores principales:	Minnema, Lotte A., Giezen, Thijs J., Hoekman, Jarno, Egberts, Toine C.G., Leufkens, Hubert G.M., Gardarsdottir, Helga
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2020
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8359229/ https://www.ncbi.nlm.nih.gov/pubmed/33278830 http://dx.doi.org/10.1002/cpt.2127

Ejemplares similares

Exploring the Association between Monoclonal Antibodies and Depression and Suicidal Ideation and Behavior: A VigiBase Study
por: Minnema, Lotte A., et al.
Publicado: (2019)

Post‐marketing dosing changes in the label of biologicals
por: Minnema, Lotte A., et al.
Publicado: (2019)

Patients Retransitioning from Biosimilar TNFα Inhibitor to the Corresponding Originator After Initial Transitioning to the Biosimilar: A Systematic Review
por: Meijboom, Rosanne W., et al.
Publicado: (2021)

Type and Extent of Information on (Potentially Critical) Quality Attributes Described in European Public Assessment Reports for Adalimumab Biosimilars
por: Alsamil, Ali M., et al.
Publicado: (2021)

Switching TNFα inhibitors: Patterns and determinants
por: Meijboom, Rosanne W., et al.
Publicado: (2021)

Adverse events related to biologicals used for patients with multiple sclerosis: a comparison between information originating from regulators and information originating from the scientific community
por: Minnema, L. A., et al.
Publicado: (2020)

Incidence of and Reasons and Determinants Associated with Retransitioning from Biosimilar Etanercept to Originator Etanercept
por: Meijboom, Rosanne W., et al.
Publicado: (2021)

Discontinuation of infliximab treatment in patients with inflammatory bowel disease who retransitioned to originator and those who remained on biosimilar
por: Meijboom, Rosanne W., et al.
Publicado: (2023)

Willingness of patients to use unused medication returned to the pharmacy by another patient: a cross-sectional survey
por: Bekker, Charlotte, et al.
Publicado: (2019)

Predicting rehospitalization in patients treated with antipsychotics: a prospective observational study
por: Abdullah-Koolmees, Heshu, et al.
Publicado: (2018)

FDA Facilitated Regulatory Pathways: Visualizing Their Characteristics, Development, and Authorization Timelines
por: Liberti, Lawrence, et al.
Publicado: (2017)

Enabling appropriate use of antibiotics: review of European Union procedures of harmonising product information, 2007 to 2020
por: Opalska, Aleksandra, et al.
Publicado: (2020)

Challenges in Advanced Therapy Medicinal Product Development: A Survey among Companies in Europe
por: ten Ham, Renske M.T., et al.
Publicado: (2018)

The Views of Healthcare Professionals, Drug Developers and Regulators on Information about Older People Needed for Rational Drug Prescription
por: Beers, Erna, et al.
Publicado: (2013)

The Use of Surrogate Endpoints in Regulating Medicines for Cardio-Renal Disease: Opinions of Stakeholders
por: Schievink, Bauke, et al.
Publicado: (2014)

Are Further Interventions Needed to Prevent and Manage Hospital-Acquired Hyponatraemia? A Nationwide Cross-Sectional Survey of IV Fluid Prescribing Practices
por: Sindahl, Per, et al.
Publicado: (2020)

Older Patients’ Compliance with Drug Storage Recommendations
por: Vlieland, Nicolaas D., et al.
Publicado: (2018)

Companies’ Health Technology Assessment Strategies and Practices in Australia, Canada, England, France, Germany, Italy and Spain: An Industry Metrics Study
por: Wang, Ting, et al.
Publicado: (2020)

Organizational capacities of national pharmacovigilance centres in Africa: assessment of resource elements associated with successful and unsuccessful pharmacovigilance experiences
por: Hilda Ampadu, H., et al.
Publicado: (2018)

Use of Dipeptidyl Peptidase-4 Inhibitors and the Reporting of Infections: A Disproportionality Analysis in the World Health Organization VigiBase
por: Willemen, Marjolein J., et al.
Publicado: (2011)

The Role of Regulator-Imposed Post-Approval Studies in Health Technology Assessments for Conditionally Approved Drugs
por: Vreman, Rick A., et al.
Publicado: (2020)

The association between prescription change frequency, chronic disease score and hospital admissions: a case control study
por: Sino, Carolien GM, et al.
Publicado: (2013)

Practical Problems with Medication Use that Older People Experience: A Qualitative Study
por: Notenboom, Kim, et al.
Publicado: (2014)

Adverse Drug Reaction Reporting in Africa and a Comparison of Individual Case Safety Report Characteristics Between Africa and the Rest of the World: Analyses of Spontaneous Reports in VigiBase(®)
por: Ampadu, Haggar H., et al.
Publicado: (2016)

Pre‐approval and post‐approval availability of evidence and clinical benefit of conditionally approved cancer drugs in Europe: A comparison with standard approved cancer drugs
por: Bloem, Lourens T., et al.
Publicado: (2022)

The Antiviral Effects of Jasminin via Endogenous TNF-α and the Underlying TNF-α-Inducing Action
por: Zhu, Xiaohong, et al.
Publicado: (2022)

New mechanisms of action and signaling by TNF-α
por: Ivashkiv, Lionel B
Publicado: (2012)

Use of Real‐World Data and Evidence in Drug Development of Medicinal Products Centrally Authorized in Europe in 2018–2019
por: Eskola, Sini Marika, et al.
Publicado: (2021)

Prescribing patterns and compliance with World Health Organization recommendations for the management of severe malaria: a modified cohort event monitoring study in public health facilities in Ghana and Uganda
por: Ampadu, H. Hilda, et al.
Publicado: (2019)

The effect of a decision support system on the incidence of prescription errors in a PICU
por: Hashemi, Fatema, et al.
Publicado: (2021)

Distinct Profiles on Subjective and Objective Adherence Measures in Patients Prescribed Antidepressants
por: Wouters, Hans, et al.
Publicado: (2019)

Pharmacists’ Activities to Reduce Medication Waste: An International Survey
por: Bekker, Charlotte L., et al.
Publicado: (2018)

Long-Term Melatonin Therapy for Adolescents and Young Adults with Chronic Sleep Onset Insomnia and Late Melatonin Onset: Evaluation of Sleep Quality, Chronotype, and Lifestyle Factors Compared to Age-Related Randomly Selected Population Cohorts
por: Zwart, Tom C., et al.
Publicado: (2018)

Monitoring of Adverse Drug Reaction-Related Parameters in Children, Youth, and Young Adults Prescribed Antipsychotic Drugs by General Practitioners
por: Minjon, Lenneke, et al.
Publicado: (2022)

Associations between uncertainties identified by the European Medicines Agency and national decision making on reimbursement by HTA agencies
por: Bloem, Lourens T., et al.
Publicado: (2021)

Anti-Xa activity after subcutaneous administration of dalteparin in ICU patients with and without subcutaneous oedema: a pilot study
por: Rommers, Mirjam K, et al.
Publicado: (2006)

Clarity and applicability of adverse drug reaction-related monitoring instructions in clinical practice guidelines for children and adolescents treated with antipsychotic drugs: a review of six clinical practice guidelines
por: Minjon, Lenneke, et al.
Publicado: (2022)

Precision medicine in diabetes and diabetic kidney disease: Regulatory considerations
por: Mol, Peter G. M., et al.
Publicado: (2018)

Association between serum biomarkers CEA and LDH and response in advanced non‐small cell lung cancer patients treated with platinum‐based chemotherapy
por: de Jong, Corine, et al.
Publicado: (2020)

Compromised Function of Regulatory T Cells in Rheumatoid Arthritis and Reversal by Anti-TNFα Therapy
por: Ehrenstein, Michael R., et al.
Publicado: (2004)

Cannot write session to /tmp/vufind_sessions/sess_l4bbp68l1sdlfmgsk2v5r7j08h